Literature DB >> 22593260

Pulmonary endarterectomy: outcomes in patients aged >70.

Marius Berman1, Gillian Hardman, Linda Sharples, Joanna Pepke-Zaba, Karen Sheares, Steven Tsui, John Dunning, David P Jenkins.   

Abstract

OBJECTIVES: Advanced age is not a barrier to cardiac surgery, with reports demonstrating excellent outcomes, but the effect of age on more complex surgery has not been studied. We assessed the outcomes of pulmonary endarterectomy (PEA) surgery in patients aged >70.
METHODS: A retrospective review of consecutive patients who underwent PEA between January 2006 and March 2011 at a national referral centre. The total cohort was dichotomized according to age on the day of surgery, either below or above 70 years. Outcomes were in-hospital mortality, overall survival and the length of ICU and hospital stays.
RESULTS: Four hundred and eleven patients underwent PEA during the 5-year period. The mean age was 56.9 years (range, 17-84 years). The in-hospital mortality was 14 of 308 (4.6%) for patients <70 years compared with 8 of 103 (7.8%) for patients ≥70 years (P = 0.21). The overall survival at 1, 2 and 3 years was 91.4, 89.9 and 87.7% in the <70-year old group and 85.9, 84.1 and 84.1% in the >70-year old group (log-rank test, P = 0.07), respectively. The length of ICU and in-hospital stays was longer in the >70-year old group, by 1 and 2 days, respectively (P = 0.005 and 0.001).
CONCLUSIONS: PEA surgery in patients ≥70 years is safe and carries a comparable risk of early mortality in younger patients, but there is an increase in resource use due to longer ICU and hospital stays. Advanced age should be taken into consideration when assessing suitability for PEA, but age per se should not be a contraindication to surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22593260     DOI: 10.1093/ejcts/ezs188

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy.

Authors:  Michael M Madani
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

2.  Pulmonary thromboendarterectomy-the Royal Papworth experience.

Authors:  David P Jenkins; Steven S Tsui; John Taghavi; Pradeep Kaul; Jason Ali; Choo Ng
Journal:  Ann Cardiothorac Surg       Date:  2022-03

3.  Pulmonary thromboendarterectomy: The Marie Lannelongue Hospital experience.

Authors:  Olaf Mercier; Clément Dubost; Amélie Delaporte; Thibault Genty; Dominique Fabre; Delphine Mitilian; Antoine Girault; Justin Issard; Arash Astaneh; Jean-Baptiste Menager; Gaelle Dauriat; Sacha Mussot; Mitja Jevnikar; Xavier Jais; Marc Humbert; Gérald Simonneau; Philippe Dartevelle; Iolando Ion; François Stephan; Philippe Brenot; Elie Fadel
Journal:  Ann Cardiothorac Surg       Date:  2022-03

Review 4.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

5.  Cardiopulmonary exercise testing suggests a beneficial response to pulmonary endarterectomy in a patient with chronic thromboembolic obstruction and normal preoperative pulmonary hemodynamics.

Authors:  Colm McCabe; Stephen D Preston; Deepa Gopalan; John Dunning; Joanna Pepke-Zaba
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

6.  High prevalence of severe coronary artery disease in elderly patients with non-operable chronic thromboembolic pulmonary hypertension referred for balloon pulmonary angioplasty.

Authors:  Marek Roik; Dominik Wretowski; Maciej Kostrubiec; Olga Dzikowska-Diduch; Andrzej Łabyk; Katarzyna Irzyk; Barbara Lichodziejewska; Anna Wyzgał; Krzysztof Jankowski; Piotr Pruszczyk
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.